Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WDR5 | P61964 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.39 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29382484 | 1.00 | WDR5 (0.44) | WDR5ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL4401115 | 0.90 | MAPT (0.43) | WDR5ALDH1A1TSHRNPSR1MAPT | |
| SCHEMBL4403131 | 0.90 | MAPT (0.43) | WDR5ALDH1A1TSHRNPSR1MAPT | |
| SCHEMBL12336891 | 0.90 | MAPT (0.43) | WDR5ALDH1A1TSHRNPSR1MAPT | |
| SCHEMBL19884356 | 0.90 | WDR5 (0.38) | WDR5ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL6053369 | 0.90 | WDR5 (0.38) | WDR5ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL11991070 | 0.90 | WDR5 (0.38) | WDR5ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL7025867 | 0.90 | KMT2A (0.42) | WDR5ALDH1A1HSD17B10NPSR1MAPT | |
| SCHEMBL18867021 | 0.89 | DNMT1 (0.39) | WDR5ALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL6242989 | 0.88 | DNMT1 (0.41) | WDR5ALDH1A1HSD17B10CYP2A6TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11355721-B2 | Organic light emitting device comprising polar matrix, metal dopant and silver cathode | NOVALED GMBH (DE) | 2022-06-07 | — | — | US | claimed |
| EP-3109915-B1 | ORGANIC LIGHT EMITTING DEVICE COMPRISING POLAR MATRIX AND METAL DOPANT | NOVALED GMBH (DE) | 2021-07-21 | — | — | EP | claimed |
| EP-3109919-B1 | N-DOPED SEMICONDUCTING MATERIAL COMPRISING POLAR MATRIX AND METAL DOPANT | NOVALED GMBH (DE) | 2021-06-23 | — | — | EP | claimed |
| US-10749115-B2 | N-doped semiconducting material comprising polar matrix and metal dopant | NOVALED GMBH (DE) | 2020-08-18 | — | — | US | claimed |
| US-20190036032-A1 | N-Doped Semiconducting Material Comprising Polar Matrix and Metal Dopant | NOVALED GMBH (DE) | 2019-01-31 | — | — | US | claimed |
| US-20180190922-A1 | Organic Light Emitting Device Comprising Polar Matrix, Metal Dopant and Silver Cathode | NOVALED GMBH (DE) | 2018-07-05 | — | — | US | claimed |
| US-20180182960-A1 | Organic Light Emitting Device Comprising Polar Matrix and Metal Dopant | NOVALED GMBH (DE) | 2018-06-28 | — | — | US | claimed |
| EP-3109919-A1 | N-DOPED SEMICONDUCTING MATERIAL COMPRISING POLAR MATRIX AND METAL DOPANT | Novaled GmbH (DE) | 2016-12-28 | — | — | EP | claimed |
| EP-3109916-A1 | ORGANIC LIGHT EMITTING DEVICE COMPRISING POLAR MATRIX, METAL DOPANT AND SILVER CATHODE | Novaled GmbH (DE) | 2016-12-28 | — | — | EP | claimed |
| EP-3109915-A1 | ORGANIC LIGHT EMITTING DEVICE COMPRISING POLAR MATRIX AND METAL DOPANT | Novaled GmbH (DE) | 2016-12-28 | — | — | EP | claimed |
| US-12416629-B2 | Hollow polymer fiber optic system for single analyte and multiplexed analyte detection | REVVITY HEALTH SCIENCES, INC. (US) | 2025-09-16 | — | — | US | disclosed |
| US-20250074925-A1 | RARE EARTH COMPLEX | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2025-03-06 | — | — | US | disclosed |
| EP-4365180-A1 | RARE EARTH COMPLEX | Tosoh Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| EP-3374538-B1 | PROCESS FOR MAKING A METAL CONTAINING LAYER | NOVALED GMBH (DE) | 2024-02-21 | — | — | EP | disclosed |
| EP-3380827-B1 | HOLLOW POLYMER FIBER OPTIC SYSTEM FOR SINGLE ANALYTE AND MULTIPLEXED ANALYTE DETECTION | REVVITY HEALTH SCIENCES INC (US) | 2023-11-29 | — | — | EP | disclosed |
| US-20020091273-A1 | Method for the regioselective preparation of substituted benzo[g]quinoline3-carbonitriles and benzo[g]quinazolines | AMERICAN HOME PRODUCTS CORPORATION | 2002-07-11 | — | — | US | disclosed |
| WO-2002053528-A1 | METHOD FOR THE REGIOSELECTIVE PREPARATION OF SUBSTITUTED BENZO[G]QUINOLINE-3-CARBONITRILES AND BENZO[G]QUINAZOLINES | WYETH (US) | 2002-07-11 | — | — | WO | disclosed |
| US-6288268-B1 | REACTION OF OLEFIN WITH ALCOHOL, OXYGEN AND CARBON MONOXIDE IN THE PRESENCE OF CATALYST FOR BISALKOXYCARBONYLATION WITH NOBLE MEYAL AND PHOSPHINE CHALCOGENIDE | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2001-09-11 | — | — | US | disclosed |
| US-6184390-B1 | Catalyst for bisalkoxycarbonylation of olefins, and method for production of succinate derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2001-02-06 | — | — | US | disclosed |
| US-6159891-A | Catalyst for bisalkoxycarbonylation of olefins, and method for production of succinate derivatives | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2000-12-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091273-A1 | Method for the regioselective preparation of substituted benzo[g]quinoline3-carbonitriles and benzo[g]quinazolines | PDXK, PKD1, PFKP | WDR5 3327/4885ALDH1A1 3804/4885HSD17B10 3378/4885 |
| US-20250074925-A1 | RARE EARTH COMPLEX | L1CAM, CHRM1, NPM1 | WDR5 3107/4885ALDH1A1 2286/4885HSD17B10 3020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.